- Taking a look at an industry in transition and what’s on the horizon
- Setting clear expectations of where we need to be 5-10 years from now
- Reviewing the challenges of cell and gene therapy production
- Discussing manufacturing platforms and capacity requirements for personalized medicine
- Examining current regulations and disruptive innovation changing the conversation